2019
DOI: 10.17116/otorino20198403174
|View full text |Cite
|
Sign up to set email alerts
|

Opportunistic fungal infections of ent organs. Part 2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…The number of patients worldwide who are at risk of AF‐related stroke is very large, and the absolute benefit of AF screening could be large 6 . Yet controversy about the utility of AF screening remains owing to concerns about potential harms resulting from screening in the absence of randomized data demonstrating the effectiveness of screening on outcomes such as stroke and bleeding 56,57 . Population‐based screening for AF has several potential benefits, including the identification of individuals with unrecognized AF, as well as an opportunity to implement more prompt interventions known to reduce AF burden and symptoms.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The number of patients worldwide who are at risk of AF‐related stroke is very large, and the absolute benefit of AF screening could be large 6 . Yet controversy about the utility of AF screening remains owing to concerns about potential harms resulting from screening in the absence of randomized data demonstrating the effectiveness of screening on outcomes such as stroke and bleeding 56,57 . Population‐based screening for AF has several potential benefits, including the identification of individuals with unrecognized AF, as well as an opportunity to implement more prompt interventions known to reduce AF burden and symptoms.…”
Section: Resultsmentioning
confidence: 99%
“…6 Yet controversy about the utility of AF screening remains owing to concerns about potential harms resulting from screening in the absence of randomized data demonstrating the effectiveness of screening on outcomes such as stroke and bleeding. 56,57 Population-based screening for AF has several potential benefits, including the identification of individuals with unrecognized AF, as well as an opportunity to implement more prompt interventions known to reduce AF burden and symptoms. Furthermore, the potential benefits gained from early identification and treatment of screen-detected AF must be balanced against the potential harms and uncertainties posed by screening.…”
Section: Clinical Complicationsmentioning
confidence: 99%
“…After the successful allogeneic transplantation from a homozygous CCR5-delta32 donor, a mutant CCR5 cell product was developed utilizing gene editing, which demonstrated its safety when administered to participants with chronic seropositive diseases (21,(37)(38)(39)(40). After the discontinuation of ART, the treated CD4+ cells are more resistant.…”
Section: Late (L)mentioning
confidence: 99%